Interim President Michael Bernstein with Elliot Bennett-Guerrero, Bettina Fries and Richard Reeder
With the world turning its attention more to treatment solutions and even potential COVID-19 cures, Stony Brook University has been leading antibody screening, enrolling patients in a convalescent plasma trial and conducting more than 180 dedicated research projects across all disciplines — all with the aim of winning the long-term Coronavirus battle. Stony Brook University Interim President Michael Bernstein hosts this episode of the “Beyond the Expected” podcast and is joined by three Stony Brook guests to talk about how our researchers have stepped up and responded, about the research they’re doing, and about the latest thinking on what antibodies can and can’t tell us about this disease.
- Dr. Elliot Bennett-Guerrero is Medical Director for Perioperative Quality and Patient Safety for Stony Brook Medicine. He’s also Professor and Vice Chairman for Clinical Research in the Department of Anesthesiology in Stony Brook University’s Renaissance School of Medicine.
- Dr. Bettina Fries is Chief of the Division of Infectious Diseases at Stony Brook Medicine, and is nationally recognized as a physician-scientist in the field of microbiology. She is a Professor of Medicine, Microbiology and Immunology at the Renaissance School of Medicine.
- Dr. Richard Reeder is Vice President for Research and serves as Associate Vice President for Brookhaven National Laboratory Affairs. He is also a member of the Brookhaven Science Associates Board of Directors and retains the position of Professor of Geochemistry in the Department of Geosciences, where he served as Chair for 2008-2013.
This episode originally aired on Facebook Live on Wednesday, May 27, 2020.